ASX Share rice
Sun 09 Aug 2020 - 03:50:am (Sydney)

IXC Share Price

INVEX THERAPEUTICS LTDIXCPharmaceuticals, Biotechnology & Life Sciences

IXC Company Information

Name:

Invex Therapeutics Ltd

Sector:

Healthcare

Industry:

Biotechnology

Address:

38 Rowland Street Subiaco WA Australia 6008

Phone:

61 8 6382 0137

Exec. Director & Chief Scientific Officer:

Dr. Alexandra Jean Sinclair

Independent Non-Exec. Director & Company Sec.:

Ms. Narelle Warren B.Com., L.L.B., B.Com, LLB

Company Overview:

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. The company was incorporated in 2019 and is based in Subiaco, Australia.

IXC Share Price Information

Shares Issued:

55M

Market Capitalisation:

$56.93M

Revenue (TTM):

$396

Earnings per Share:

$-0.03

Operating Margin (TTM):

$-962.27

Gross Profit(TTM):

$396

Diluted Earnings Per Share (TTM):

$-0.03

IXC CashFlow Statement

CashFlow Date:

2019-06-30

Change To Liabilities:

$61.50K

Total Cashflow From Investing Activities:

$-24,573

Net Income:

$-696,366

Total Cash From Operating Activities:

$-690,396

Change To Account Receivables:

$-55,530

Capital Expenditures:

$0

IXC Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-696,366

Net Income:

$-696,366

Gross Profit:

$396

Operating Income:

$-381,060

Total Revenue:

$396

Total Operating Expenses:

$381.46K

IXC Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$117.95K

Total Liabilities:

$0.94M

Total Stockholder Equity:

$11.44M

Total Assets:

$12.37M

Common Stock:

$12.61M

Retained Earnings:

$-232,122

Cash:

$12.17M

Total Current Liabilities:

$0.94M

Net Tangible Assets:

$11.32M

Total Current Assets:

$12.26M

Net Receivables:

$85.62K

Accounts Payable:

$0.94M

IXC Share Price History

IXC News